HEALTHCARE
HUMAN INSULIN MARKET
FORECASTS TO 2020
REPORT CODE BT 3981
HUMAN INSULIN MARKET - FORECASTS TO 2020
Drugs ( Biologics , Biosimilars ), Type ( Short Acting , Long Acting , Premixed ), Brands ( Lantus , Novorapid , Humalog ), Delivery Devices ( Pens , Pen Needles , Syringes ), Applications ( Type 1 Diabetes , Type 2 Diabetes )
REPORT OVERVIEW
1.1 OBJECTIVES OF THE STUDY
• To define , describe , and forecast the global human insulin market on the basis of product , human insulin drugs type , human insulin drugs brand , delivery device , and application
• To provide detailed information regarding major factors influencing growth of the market ( drivers , restraints , opportunities , and challenges )
• To strategically analyze micromarkets with respect to individual growth trends , future prospects , and contributions to the overall market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for leading market players
• To forecast the size of the market segments with respect to four main regions , namely , North America ( U . S . and Canada ), Europe ( Germany , France , U . K ., and Rest of Europe ), Asia-Pacific ( Japan , China , India , and Rest of Asia-Pacific ), and the Rest of the World
• To strategically profile the key market players and comprehensively analyze their market shares and core competencies
• To track and analyze competitive developments such as joint ventures ; mergers and acquisitions ; new product developments ; and partnerships , agreements , and collaborations in the human insulin market
sales @ marketsandmarkets . com www . marketsandmarkets . com
1